Primary clarithromycin resistance to Helicobacter pylori: Is this the main reason for triple therapy failure?

doi:10.4291/wjgp.v4.i3.43

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5490)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

367

HTML

3331

Figures (1-1)

164

Sum=3862

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

910

Download

718

Sum=1628

Aug 15, 2013 (publication date) through May 6, 2024

Times Cited of This Article

Times Cited (27)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pathophysiology

ISSN

2150-5330

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Frontier

World J Gastrointest Pathophysiol. Aug 15, 2013; 4(3): 43-46
Published online Aug 15, 2013. doi: 10.4291/wjgp.v4.i3.43

Open in New Tab Full Size Figure Download Figure

Figure 1 Secondary structure model of the peptidyltransferase region in domain V of the Helicobacter pylori 23S rRNA. The site of the A2142C, A2142G and A2143G mutations is underlined.

Citation: Giorgio F, Principi M, De Francesco V, Zullo A, Losurdo G, Di Leo A, Ierardi E. Primary clarithromycin resistance to Helicobacter pylori: Is this the main reason for triple therapy failure? World J Gastrointest Pathophysiol 2013; 4(3): 43-46
URL: https://www.wjgnet.com/2150-5330/full/v4/i3/43.htm
DOI: https://dx.doi.org/10.4291/wjgp.v4.i3.43